Innovative ETFs ChannelBiotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 ResearchBy Max ChenJuly 7, 2020
Innovative ETFs ChannelBiotech ETFs Rally After Inovio Locks in DOD Coronavirus DealBy Max ChenJune 23, 2020
Disruptive Technology ChannelWhy ETF Investors Should Consider Allocating to InnovationBy Max ChenMay 14, 2020
Disruptive Technology ChannelMaking the Case for Innovation: Rethinking Traditional Asset AllocationBy Max ChenMay 13, 2020
Equity ETF ChannelHealth Care Sector ETFs May Not Be so Defensive This Time AroundBy Max ChenMay 1, 2020
Tactical Allocation ChannelHealthcare ETFs Strengthen on Hopes of Combating CoronavirusBy Max ChenMarch 30, 2020
Disruptive Technology ChannelA Q&A with Trusted Experts to Help Clarify the UncertaintyBy Max ChenMarch 26, 2020
Disruptive Technology ChannelArtificial Intelligence is Helping Doctors Track the CoronavirusBy Ben HernandezMarch 9, 2020
Disruptive Technology ChannelETFs to Tap into Disruptive Technologies That Can Revolutionize the WorldBy Max ChenMarch 2, 2020
Disruptive Technology ChannelA Targeted Biotech ETF Is Brushing Off the SellingBy Max ChenFebruary 27, 2020
Thematic Investing ChannelPrognosis For This China ETF Is Very Healthy IndeedBy Tom LydonFebruary 20, 2020
Core Equity ChannelDon’t Overlook Healthcare Sector ETFs Even in an Election YearBy Max ChenFebruary 17, 2020
Core Equity ChannelSmall-Cap Health Care ETF Has Been Producing Healthy ReturnsBy Max ChenFebruary 12, 2020
Disruptive Technology ChannelBiotech ETFs Are Not Riding the Wave from Coronavirus PanicBy Max ChenJanuary 24, 2020
